Curaleaf Q3 Results: Strong Margins But $44M Loss, What’s Next For Investors?

The company reported a net loss of $44 million, equivalent to $0.07 per share, with adjusted EBITDA at $75.3 million.

read more

Leave a Reply

Your email address will not be published. Required fields are marked *